Skip to content
Governance Register

Company

Otsuka Pharmaceuticals (U.K.) LTD.

Otsuka Pharmaceuticals (U.K.) LTD. is an active UK company (number 03615891), incorporated 1998, with 2 current directors, Annabel Barbara O'Connor and Ryan Gynne. Source: Companies House, updated 11th October 2026.

Create a free account to see who leads this organisation and how they are connected.

Official record Companies House · updated 11th October 2026 · Sources · Free, no card or password

Network

The large node is Otsuka Pharmaceuticals (U.K.) LTD.. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 12

  1. Stewart Benjamin Pearce 2017-2020 Director View profile
  2. Cheryl Charanjit Dhillon 2016-2020 Director View profile
  3. David Gower Bevan 2014-2016 Director View profile
  4. Andrew Edward Page 2014-2017 Director View profile
  5. Dhillon, Charanjit, Cheryl 2009-2014 Director View profile
  6. Tetsusaburo Hori 2005-2009 Director View profile
  7. Tadasu Toba 2002-2005 Director View profile
  8. Hiromi Yoshikawa 1998-2002 Director View profile
  9. Grant Geddes 1998-2014 Director View profile
  10. Klaus Juelicher 1998-2002 Director View profile
  11. Michael William Rich 1998-1998 Nominee-director View profile
  12. Barbara Reeves 1998-1998 Nominee-director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

Public contracts won

2 contracts · £15,529,352 total

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

  • NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

    NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

    Framework
  • NHS National Framework for Aripiprazole prolonged release injection Buyer: NHS England Value not published Date not published Source: Find a Tender

    Project title: NHS National Framework for Aripiprazole prolonged release injection commencing 1st February 2027 Offer reference number: CM/TNS/26/5741 Period of framework agreement: Dates detailed below, with an option or options to extend …

    Framework

About

Incorporated
14/08/1998

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Otsuka Pharmaceuticals (U.K.) LTD. is controlled by Otsuka Pharmaceutical Europe LTD.
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors, significant influence · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by Otsuka Pharmaceutical Europe LTD..

1 other company in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

6.3y median 6.3y
average tenure
6.7y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (2)

0
also govern a charity
0
left in the last 12 months

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
03615891
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 11th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data